Trust but verify: Is there a role for active surveillance in monitoring adverse events in Zimbabwe's large-scale male circumcision program?
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
13
03
2019
accepted:
26
05
2019
entrez:
11
6
2019
pubmed:
11
6
2019
medline:
25
2
2020
Statut:
epublish
Résumé
Ensuring quality service provision is fundamental to ZAZIC's voluntary medical male circumcision (MC) program in Zimbabwe. From October, 2014 to September, 2017, ZAZIC conducted 205,847 MCs. Passive surveillance recorded a combined moderate and severe adverse event (AE) rate of 0.3%; reported adherence to follow-up was 95%, suggesting program safety. Despite encouraging passive surveillance data, verification of data quality and accuracy would increase confidence in AE identification. From May to August, 2017, ZAZIC implemented a focused quality assurance (QA) study on AE ascertainment and documentation at 6 purposively-selected, high-volume MC sites. ZAZIC Gold-Standard (GS) clinicians prospectively observed 100 post-MC follow-ups per site in tandem with facility-based MC providers to confirm and characterize AEs, providing mentoring in AE management when needed. GS clinicians also retrospectively reviewed site-based, routine MC data, comparing recorded to reported AEs, and held brief qualitative interviews with site leadership on AE-related issues. Observed AE rates varied from 1-8%, potentially translating to thousands of unidentified AEs if observed AE rates were applied to previous MC performance. Most observed AEs were infections among younger clients. Retrospective review found discrepancies in AE documentation and reporting. Interviews suggest human resource and transport issues challenge MC follow-up visit attendance. Post-operative self-care appears to produce generally good results for adults; however, younger clients and guardians need additional attention to ensure quality care. There was no evidence of missed severe AEs resulting in permanent impairment or morbidity. Although results cannot be generalized, active surveillance suggests that AEs may be higher and follow-up lower than reported. In response, ZAZIC's Quality Assurance Task Force will replicate this QA study in other sites; increase training in AE identification, management, and documentation for clinical and data teams; and improve post-operative counseling for younger clients. Additional nurses and vehicles, especially in rural health clinics, could be beneficial.
Identifiants
pubmed: 31181096
doi: 10.1371/journal.pone.0218137
pii: PONE-D-19-07338
pmc: PMC6557516
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0218137Subventions
Organisme : CGH CDC HHS
ID : U2G GH000972
Pays : United States
Organisme : PEPFAR
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS One. 2017 Dec 22;12(12):e0190055
pubmed: 29272320
Pan Afr Med J. 2014 Nov 14;19:278
pubmed: 25870733
BMC Health Serv Res. 2015 Jun 18;15:235
pubmed: 26084777
PLoS One. 2015 Jul 24;10(7):e0133369
pubmed: 26207986
MMWR Morb Mortal Wkly Rep. 2016 Jan 22;65(2):36-7
pubmed: 26797167
Glob Health Action. 2018;11(1):1414997
pubmed: 29322867
J Int AIDS Soc. 2014 Nov 17;17:19275
pubmed: 25406951
Bull World Health Organ. 2012 Oct 1;90(10):773-81
pubmed: 23109745
BMC Health Serv Res. 2016 Feb 17;16:61
pubmed: 26888178
PLoS Med. 2010 Jul 20;7(7):e1000309
pubmed: 20652013
J Int AIDS Soc. 2017 Feb 20;19(1):21394
pubmed: 28362066
Health Res Policy Syst. 2014 Jan 30;12:7
pubmed: 24479822
Bull World Health Organ. 2008 Sep;86(9):669-77
pubmed: 18797642
BMJ Open. 2017 Jan 27;7(1):e013562
pubmed: 28132009
Clin Infect Dis. 2018 Apr 3;66(suppl_3):S161-S165
pubmed: 29617774
PLoS One. 2018 Sep 7;13(9):e0203292
pubmed: 30192816
Lancet. 2007 Feb 24;369(9562):657-66
pubmed: 17321311
Clin Infect Dis. 2018 Apr 3;66(suppl_3):S198-S204
pubmed: 29617772
PLoS Med. 2005 Nov;2(11):e298
pubmed: 16231970
Lancet. 2007 Feb 24;369(9562):643-56
pubmed: 17321310
Clin Infect Dis. 2018 Apr 3;66(suppl_3):S229-S235
pubmed: 29617777
J Acquir Immune Defic Syndr. 2015 May 1;69(1):e13-23
pubmed: 25942466